Scott M Whitcup's Net Worth

$26.6 Million

Estimate Recalculated Nov 1, 2024 09:19AM EST

Who is Scott M Whitcup?

Scott M Whitcup has an estimated net worth of $26.6 Million. This is based on reported shares across multiple companies, which include Nightstar Therapeutics plc, Menlo Therapeutics Inc., Adverum Biotechnologies, Inc., ALLERGAN INC, QUESTCOR PHARMACEUTICALS INC, and AVANIR PHARMACEUTICALS.

SEC CIK

Scott M Whitcup's CIK is 0001298941

Past Insider Trading and Trends

2013 was Scott M Whitcup's most active year for acquiring shares with 15 total transactions. Scott M Whitcup's most active month to acquire stocks was the month of January. 2013 was Scott M Whitcup's most active year for disposing of shares, totalling 24 transactions. Scott M Whitcup's most active month to dispose stocks was the month of February. 2014 saw Scott M Whitcup paying a total of $12,932,722.05 for 167,015 shares, this is the most they've acquired in one year. In 2014 Scott M Whitcup cashed out on 247,403 shares for a total of $12,468,137.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nightstar Therapeutics plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-74.57K
$25.50
-$1,901,484.00
0
Jun 7
Form 4
—
0
—
—
0
Jan 25
Form 3
—
0
—
—
0
No matching records found

Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found

Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Apr 16
Form 3
—
0
—
—
0
No matching records found

ALLERGAN INC No price found

Executive VP, R&D, CSO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-20.62K
—
—
0
Feb 20 - Mar 17
Form 4
+0.77%
132
$234.00
-$18,720.00
17.18K
Feb 20
Form 4
—
0
—
—
0
Feb 21
Form 4
-1.64%
-284.00
$124.57
-$35,377.88
17.04K
Feb 14
Form 4
—
0
$86.89
-$2,596,650.00
17.33K
Scheduled
Jan 14
Form 4
—
0
$84.89
-$2,428,650.00
17.33K
Scheduled
Jan 8
Form 4/A
—
0
$73.97
-$1,830,730.00
17.33K
Scheduled
Jan 3
Form 4
—
0
$108.80
-$3,590,400.00
17.33K
Scheduled
Dec 20
Form 4
—
0
$72.47
-$2,397,450.00
17.33K
Scheduled
Dec 20
Form 4
—
0
$75.58
-$946,594.25
17.33K
Scheduled
Apr 11
Form 4
—
0
$75.58
-$1,040,425.75
17.33K
Scheduled
Apr 3
Form 4
—
0
$76.47
-$563,702.40
17.33K
Scheduled
Apr 1
Form 4
—
0
$74.08
-$871,061.40
17.33K
Scheduled
Mar 26
Form 4
—
0
$74.08
-$463,898.60
17.33K
Scheduled
Mar 21 - Mar 25
Form 4
-23.14%
-5.22K
$108.08
-$563,961.44
17.33K
Feb 20 - Feb 21
Form 4
-1.89%
-434.00
$108.02
-$46,880.68
22.55K
Feb 15
Form 4
—
0
$69.02
-$1,333,440.00
22.98K
Scheduled
Jan 4
Form 4
—
0
$60.68
-$415,541.20
22.98K
Scheduled
Dec 7
Form 4
—
0
$62.42
-$322,875.00
22.98K
Scheduled
Oct 17
Form 4
—
0
$61.42
-$375,450.00
22.98K
Scheduled
Oct 1
Form 4
—
0
$60.42
-$90,874.35
22.98K
May 30
Form 4
—
0
$61.07
-$92,812.50
22.98K
May 16
Form 4
-0.20%
-45.00
$87.27
-$3,927.15
22.98K
Feb 22
Form 4
+2.42%
544
—
—
23.02K
Feb 17
Form 4
-6.14%
-1.47K
$88.11
-$129,514.35
22.48K
Feb 14
Form 4
—
0
$56.41
-$302,339.95
23.95K
Scheduled
May 18
Form 4
-2.48%
-607.95
$80.85
-$49,151.93
23.95K
May 11
Form 4
—
0
$54.86
-$103,760.00
24.56K
Scheduled
May 4
Form 4
+3.50%
830
—
—
24.56K
Feb 17
Form 4
-14.43%
-4.00K
$75.72
-$302,891.20
23.73K
Feb 17
Form 4
—
0
$54.79
-$441,475.35
27.73K
Scheduled
Dec 14
Form 4
—
0
$53.62
-$200,190.72
27.73K
Scheduled
Dec 1
Form 4
—
0
$48.80
-$236,624.28
27.73K
Scheduled
Mar 31
Form 4
+0.43%
120
—
—
27.73K
Feb 22
Form 4
-2.67%
-756.00
$58.97
-$44,577.54
27.61K
Feb 12
Form 4
—
0
$47.30
-$238,450.40
28.36K
Scheduled
Dec 22
Form 4
—
0
$45.30
-$129,031.50
28.36K
Scheduled
Sep 16
Form 4
—
0
$42.87
-$41,912.60
28.36K
Scheduled
Jul 30
Form 4
+54.46%
10K
—
—
28.36K
Feb 20
Form 4
-3.08%
-584.00
$38.37
-$22,405.16
18.36K
Feb 2
Form 4
+46.31%
6K
—
—
18.95K
Feb 14
Form 4
-5.32%
-728.00
$66.66
-$48,524.84
12.95K
Feb 6
Form 4
-13.68%
-2.17K
$64.00
-$138,752.00
13.68K
Jan 30
Form 4
—
0
$114.94
-$124,399.12
7.92K
Scheduled
May 31 - Jun 1
Form 4
—
0
$115.63
-$1,874.00
7.92K
Scheduled
May 24
Form 4
+9.42%
682
—
—
7.92K
Feb 2
Form 4
-19.90%
-1.80K
$115.80
-$208,324.20
7.24K
Jan 31
Form 4
—
0
$104.28
-$228,515.70
9.04K
Scheduled
Nov 20
Form 4
—
0
$82.92
-$564,300.00
9.04K
Jul 11
Form 4
—
0
$78.63
-$580,983.84
9.04K
Jun 16
Form 4
—
0
$78.63
-$263,700.00
9.04K
Jun 12
Form 4
—
0
$80.56
-$311,300.00
9.04K
Apr 3
Form 4
+12.69%
1.02K
—
—
9.04K
Feb 6
Form 4
—
0
—
—
0
Feb 9
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

QUESTCOR PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.18K
—
—
0
Aug 14
Form 4
∞
4.18K
—
—
4.18K
May 24
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
Feb 15
Form 3
—
0
—
—
0
No matching records found